PROGESTERONE (Gepretix®)
Clinical Indication
For adjunctive use with an oestrogen in post-menopausal women with an intact uterus, as hormone replacement therapy (HRT).
Date of classification
September 2023
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.